HALO vs. HELO
HALO (Halozyme Therapeutics, Inc.) is a stock, while HELO (JPMorgan Hedged Equity Laddered Overlay ETF) is Options Trading fund actively managed by JPMorgan. Over the past year, HALO returned 19.12% vs 11.65% for HELO. At a 0.28 correlation, their price movements are largely independent.
Performance
HALO vs. HELO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HALO achieves a -1.52% return, which is significantly lower than HELO's 2.52% return.
HALO
- 1D
- -2.73%
- 1M
- 3.63%
- YTD
- -1.52%
- 6M
- -0.39%
- 1Y
- 19.12%
- 3Y*
- 25.45%
- 5Y*
- 11.28%
- 10Y*
- 21.28%
HELO
- 1D
- -0.07%
- 1M
- 0.73%
- YTD
- 2.52%
- 6M
- 3.21%
- 1Y
- 11.65%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HALO vs. HELO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | -1.52% | 40.77% | 29.36% | -3.25% |
HELO JPMorgan Hedged Equity Laddered Overlay ETF | 2.52% | 7.82% | 18.05% | 6.30% |
Correlation
The correlation between HALO and HELO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2023 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HALO vs. HELO — Risk / Return Rank
HALO
HELO
HALO vs. HELO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and JPMorgan Hedged Equity Laddered Overlay ETF (HELO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HALO | HELO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | 1.89 | -1.24 |
Sortino ratioReturn per unit of downside risk | 1.06 | 2.65 | -1.59 |
Omega ratioGain probability vs. loss probability | 1.13 | 1.38 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | 0.75 | 2.05 | -1.30 |
Martin ratioReturn relative to average drawdown | 1.45 | 9.10 | -7.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HALO | HELO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 1.89 | -1.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.29 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.50 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 1.65 | -1.42 |
Drawdowns
HALO vs. HELO - Drawdown Comparison
The maximum HALO drawdown since its inception was -74.26%, which is greater than HELO's maximum drawdown of -10.89%. Use the drawdown chart below to compare losses from any high point for HALO and HELO.
Loading charts...
Drawdown Indicators
| HALO | HELO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.26% | -10.89% | -63.37% |
Max Drawdown (1Y)Largest decline over 1 year | -24.13% | -5.76% | -18.37% |
Max Drawdown (3Y)Largest decline over 3 years | -33.92% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -49.06% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -49.06% | — | — |
Current DrawdownCurrent decline from peak | -18.40% | -0.07% | -18.33% |
Average DrawdownAverage peak-to-trough decline | -31.91% | -1.18% | -30.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.56% | 1.30% | +11.26% |
Volatility
HALO vs. HELO - Volatility Comparison
Halozyme Therapeutics, Inc. (HALO) has a higher volatility of 10.41% compared to JPMorgan Hedged Equity Laddered Overlay ETF (HELO) at 0.66%. This indicates that HALO's price experiences larger fluctuations and is considered to be riskier than HELO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HALO | HELO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.41% | 0.66% | +9.75% |
Volatility (6M)Calculated over the trailing 6-month period | 24.18% | 5.00% | +19.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.89% | 6.20% | +23.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.47% | 7.96% | +31.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.89% | 7.96% | +34.93% |
Dividends
HALO vs. HELO - Dividend Comparison
HALO has not paid dividends to shareholders, while HELO's dividend yield for the trailing twelve months is around 0.62%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
HELO JPMorgan Hedged Equity Laddered Overlay ETF | 0.62% | 0.67% | 0.60% | 0.19% |
Frequently Asked Questions
HALO and HELO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HALO has higher volatility (10.41%) compared to HELO (0.66%). In terms of maximum drawdown, HALO dropped -74.26% vs HELO's -10.89%.
HELO currently has the higher Sharpe Ratio (1.89 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HALO and HELO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer